Q&A on “Time for $5”, a campaign for affordable diagnostic tests

The “Time for $5” campaign calls on Cepheid and its parent corporation, Danaher, to prioritise people over profits and reduce the price of GeneXpert tests to $5

In open letters, civil society organisations call on Abbott and BD Biosciences to ensure access to CD4 diagnostic tests critical for HIV care

Global access to point-of-care CD4 devices and tests is under threat

The challenges and opportunities offered by increasing local production of diagnostic tests in the African region

Following a roundtable discussion with funders, governments and other procurers, a set of principles has been developed to enable better outcomes to negotiations with diagnostic manufacturers.